
Abeona Therapeutics Inc is a biotechnology business based in the US. Abeona Therapeutics shares (ABEO) are listed on the NASDAQ and all prices are listed in US Dollars. Abeona Therapeutics employs 90 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Abeona Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ABEO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Abeona Therapeutics stock price (NASDAQ: ABEO)
Use our graph to track the performance of ABEO stocks over time.Abeona Therapeutics shares at a glance
Latest market close | $0.19 |
---|---|
52-week range | $0.13 - $1.56 |
50-day moving average | $0.18 |
200-day moving average | $0.45 |
Wall St. target price | $2.33 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.81 |
Buy Abeona Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Abeona Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Abeona Therapeutics price performance over time
Historical closes compared with the close of $0.19 from 2022-07-01
1 week (2022-06-28) | 3.15% |
---|---|
1 month (2022-06-01) | 22.50% |
3 months (2022-04-05) | -44.30% |
6 months (2022-01-05) | -40.68% |
1 year (2021-07-02) | -87.74% |
---|---|
2 years (2020-07-02) | -93.33% |
3 years (2019-07-05) | 4.56 |
5 years (2017-07-05) | 7.3 |
Abeona Therapeutics financials
Revenue TTM | $3.3 million |
---|---|
Gross profit TTM | $-299,000 |
Return on assets TTM | -36.37% |
Return on equity TTM | -142.61% |
Profit margin | 0% |
Book value | $0.21 |
Market capitalisation | $30.6 million |
TTM: trailing 12 months
Abeona Therapeutics share dividends
We're not expecting Abeona Therapeutics to pay a dividend over the next 12 months.
Have Abeona Therapeutics's shares ever split?
Abeona Therapeutics's shares were split on a 1:50 basis on 23 October 2014. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Abeona Therapeutics shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Abeona Therapeutics shares which in turn could have impacted Abeona Therapeutics's share price.
Abeona Therapeutics share price volatility
Over the last 12 months, Abeona Therapeutics's shares have ranged in value from as little as $0.13 up to $1.56. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abeona Therapeutics's is 1.5. This would suggest that Abeona Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Abeona Therapeutics overview
Abeona Therapeutics Inc. , a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc.
Abeona Therapeutics in the news
F-star (FSTX) Stock Rises on Buyout Offer From Sino Biopharm
FDA Committee Endorses bluebird's (BLUE) Thalassemia Therapy
FDA Committee Recommends bluebird's (BLUE) CALD Therapy
Frequently asked questions
What percentage of Abeona Therapeutics is owned by insiders or institutions?Currently 10.263% of Abeona Therapeutics shares are held by insiders and 21.888% by institutions. How many people work for Abeona Therapeutics?
Latest data suggests 90 work at Abeona Therapeutics. When does the fiscal year end for Abeona Therapeutics?
Abeona Therapeutics's fiscal year ends in December. Where is Abeona Therapeutics based?
Abeona Therapeutics's address is: 1330 Avenue of the Americas, New York, NY, United States, 10019 What is Abeona Therapeutics's ISIN number?
Abeona Therapeutics's international securities identification number is: US00289Y1073 What is Abeona Therapeutics's CUSIP number?
Abeona Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00289Y107
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert